Suitability of a High-energy, Low-protein Formula (Renalive® LP)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFresenius Kabi Taiwan Ltd.
About this trial
Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2)
Exclusion criteria
(1) Has received dialysis or are expected to start dialysis within the next 3 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Renalive® LP,
Dietary supplementflavour
Treatment groups
80 Participants
are divided into 1 treatment groupGroup A: Renalive® LPExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in body weight from Baseline to end of treatment at Week 4 (Week 4 - Baseline)
Time frame
4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov